4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001415889-22-006631
EVP, CHIEF SCIENTIFIC OFFICER sold 5,145 shares at $10.06 ($51,745)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 2022-06-15 | Sale | −5,145 | $10.06 | $51,745 | 68,349 | D |
| Open-market sales · 5,145 sh · avg $10.06 · $51,745 | |||||||
Loading xslF345X03/form4-06162022_040601.xml…